These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22596098)

  • 1. A novel quadraport needle with improved intravitreal drug dispersion.
    Asami T; Wong SC; Mitchell PC; Tokunaga CC; Chen YH; Dang L; Giblin FJ; Trese MT
    Retina; 2012 Jun; 32(6):1222-5. PubMed ID: 22596098
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitreous levels of active ocriplasmin following intravitreal injection: results of an ascending exposure trial.
    Stalmans P; Girach A
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6620-7. PubMed ID: 23982845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal drug dispersion and needle gauge.
    Montero JA; Merino-Iglesias AA; Pérez-Martín S; Ruiz-Moreno JM
    Acta Ophthalmol; 2013 Dec; 91(8):e646-7. PubMed ID: 23890329
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreally Injected Fluid Dispersion: Importance of Injection Technique.
    Willekens K; Reyns G; Diricx M; Vanhove M; Noppen B; Coudyzer W; Ni Y; Feyen JH; Stalmans P
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1434-1441. PubMed ID: 28264098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
    Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
    Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
    Sakuma T; Mizota A; Inoue J; Tanaka M
    Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental investigation of needles, syringes and techniques for intravitreal injections.
    De Stefano VS; Abechain JJ; de Almeida LF; Verginassi DM; Rodrigues EB; Freymuller E; Maia M; Magalhaes O; Nguyen QD; Farah ME
    Clin Exp Ophthalmol; 2011 Apr; 39(3):236-42. PubMed ID: 20973898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocriplasmin: a medical or surgical therapy?
    Duker JS; Moshfeghi AA
    Retina; 2013; 33(10):2001-2. PubMed ID: 24113274
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Gandorfer A; Kampik A
    Am J Ophthalmol; 2006 Apr; 141(4):784-5; author reply 785. PubMed ID: 16564844
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonclinical safety and pharmacokinetics of intravitreally administered human-derived plasmin in rabbits and minipigs.
    Proksch JW; Driot JY; Vandeberg P; Ward KW
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):320-32. PubMed ID: 18476803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tower microneedle minimizes vitreal reflux in intravitreal injection.
    Lee CY; You YS; Lee SH; Jung H
    Biomed Microdevices; 2013 Oct; 15(5):841-8. PubMed ID: 23666517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravitreal enzyme therapy and early transplantation of the vitreous body in experimental hemophthalmos].
    Lebekhov PI; Faĭnshteĭn EIa
    Vestn Oftalmol; 1980; (2):26-8. PubMed ID: 6446184
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.
    Laude A; Tan LE; Wilson CG; Lascaratos G; Elashry M; Aslam T; Patton N; Dhillon B
    Prog Retin Eye Res; 2010 Nov; 29(6):466-75. PubMed ID: 20452456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.
    Elbendary AM; Elwan MM; Azzam HA; Eldeeb DR
    Curr Eye Res; 2011 Jun; 36(6):534-9. PubMed ID: 21591862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Takano A; Hirata A; Inomata Y; Kawaji T; Nakagawa K; Nagata S; Tanihara H
    Am J Ophthalmol; 2005 Oct; 140(4):654-60. PubMed ID: 16140249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections.
    Melo GB; Cruz NFSD; Emerson GG; Rezende FA; Meyer CH; Uchiyama S; Carpenter J; Shiroma HF; Farah ME; Maia M; Rodrigues EB
    Prog Retin Eye Res; 2021 Jan; 80():100862. PubMed ID: 32311476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel use of intravitreal injection callipers.
    Khan K; Vize C
    Eye (Lond); 2009 Aug; 23(8):1751. PubMed ID: 18989349
    [No Abstract]   [Full Text] [Related]  

  • 18. A calipers-free intravitreal anti-VEGF injection technique.
    Oztas Z; Akkin C; Afrashi F; Selim S
    Arq Bras Oftalmol; 2015; 78(2):133-4. PubMed ID: 25945539
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental model of intravitreal injection techniques.
    Hubschman JP; Coffee RE; Bourges JL; Yu F; Schwartz SD
    Retina; 2010 Jan; 30(1):167-73. PubMed ID: 19779317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and treatment of vitreous hemorrhage.
    Goff MJ; McDonald HR; Johnson RN; Ai E; Jumper JM; Fu AD
    Compr Ophthalmol Update; 2006; 7(3):97-111. PubMed ID: 16882398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.